Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
letter
. 2007 Jul;115(7):A341–A342. doi: 10.1289/ehp.10151

Copper Deficiency, Lead, and Paraoxonase

Leslie M Klevay 1
PMCID: PMC1913565  PMID: 17637895

Li et al. (2006) measured paraoxonase 1 (PON1) in workers and found an inverse association between lead exposure and enzyme activity. This observation compliments some epidemiology and related experiments with animals, because low paraoxonase activity is associated with diabetes mellitus, familial hypercholesterolemia, ischemic heart disease, and metabolic syndrome (Klevay 2004). Paraoxonase, although studied most extensively because of its ability to detoxify organophosphate insecticides (James 2006; van Himbergen et al. 2006), has drawn increasing attention because it hydrolyzes homocysteine thiolactone, a vascular toxin that inhibits copper enzymes (Klevay 2006).

Lead intoxication has many manifestations (Fischbein 1998), lesser-known of which is induction of copper deficiency (Klauder and Petering 1977). Rats deficient in copper have an approximately 28% decrease in paraoxonase activity (Klevay 2004). These observations are consonant with the decrease in superoxide dismutase (SOD) associated with occupational exposure to lead (Ito et al. 1985) because this enzyme also depends on adequate copper nutriture for activity (Linder and Goode 1980; Owen 1981). Thus, SOD is an index of copper nutriture in humans (Uauy et al. 1985).

Li et al. (2006) stated that “the mechanism by which heavy metals inhibit serum PON1 activity is still not clear.” It seems likely that lead interferes with copper utilization in the workers, leading to low copper nutritional status (Li et al. 2006). Low copper status has been related to a large variety of adverse cardiovascular phenomena in both animals and people; in this context, the most important are hypercholesterolemia, hypertension, and impaired oxidative defense (Klevay 2000, 2002).

Are there unpublished copper data on the workers, or can they be reexamined to test this copper hypothesis? Plasma copper and ceruloplasmin are not likely to be useful because they are increased by inflammation (Pepys 1996) and may be falsely high. Extracellular SOD may be helpful because it is sensitive to low copper status (Johnson et al. 2005), and low values have been associated with atherosclerosis in humans (Landmesser et al. 2000; Wang et al. 1998).

References

  1. Fischbein A. Occupational and environmental exposure to lead. In: Rom WN, editor. Environmental & Occupational Medicine. Philadelphia: Lippincott-Raven; 1998. pp. 973–996. [Google Scholar]
  2. Ito Y, Niiya Y, Kurita H, Shima S, Sarai S. Serum lipid peroxide level and blood superoxide dismutase activity in workers with occupational exposure to lead. Int Arch Occup Environ Health. 1985;56:119–127. doi: 10.1007/BF00379383. [DOI] [PubMed] [Google Scholar]
  3. James RW. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med. 2006;44:1052–1059. doi: 10.1515/CCLM.2006.207. [DOI] [PubMed] [Google Scholar]
  4. Johnson WT, Johnson LA, Lukaski HC. Serum superoxide dismutase 3 (extracellular superoxide dismutase) activity is a sensitive indicator of Cu status in rats. J Nutr Biochem. 2005;16:682–692. doi: 10.1016/j.jnutbio.2005.03.009. [DOI] [PubMed] [Google Scholar]
  5. Klauder DS, Petering HG. Anemia of lead intoxication: a role for copper. J Nutr. 1977;107:1779–1785. doi: 10.1093/jn/107.10.1779. [DOI] [PubMed] [Google Scholar]
  6. Klevay LM. Trace element and mineral nutrition in disease: ischemic heart disease. In: Bogden JD, Klevay LM, editors. Clinical Nutrition of the Essential Trace Elements and Minerals: The Guide for Health Professionals. Totowa, NJ: Humana Press Inc; 2000. pp. 251–271. [Google Scholar]
  7. Klevay LM. Advances in cardiovascular-copper research. In: Schrauzer GN, editor. First International Bio-minerals Symposium: Trace Elements in Nutrition, Health and Disease. Montreal, Quebec, Canada: Institut Rosell; 2002. pp. 64–71. [Google Scholar]
  8. Klevay LM. Ischemic heart disease as deficiency disease. Cell Mol Biol (Noisy-le-grand) 2004;50:877–884. [PubMed] [Google Scholar]
  9. Klevay LM. How dietary deficiency, genes and a toxin can cooperate to produce arteriosclerosis and ischemic heart disease. Cell Mol Biol (Noisy-le-grand) 2006;52:11–15. [PubMed] [Google Scholar]
  10. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B. Vascular extracellular super-oxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation. 2000;101:2264–2270. doi: 10.1161/01.cir.101.19.2264. [DOI] [PubMed] [Google Scholar]
  11. Li WF, Pan MH, Chung MC, Ho CK, Chuang HY. Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes. Environ Health Perspect. 2006;114:1233–1236. doi: 10.1289/ehp.9163. [Online 18 May 2006] [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Linder MC, Goode CA. Biochemistry of Copper. New York: Plenum Press; 1980. [Google Scholar]
  13. Owen CA., Jr . Copper Deficiency and Toxicity. Park Ridge, N.J: Noyes Publication; 1981. [Google Scholar]
  14. Pepys MB. The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JG, Warrell DA, editors. Oxford Textbook of Medicine. Oxford, UK: Oxford University Press; 1996. pp. 1527–1533. [Google Scholar]
  15. Uauy R, Castillo-Duran C, Fisberg M, Fernandez N, Valenzuela A. Red cell superoxide dismutase activity as an index of human copper nutrition. J Nutr. 1985;115:1650–1655. doi: 10.1093/jn/115.12.1650. [DOI] [PubMed] [Google Scholar]
  16. van Himbergen TM, van Tits LJ, Roest M, Stalenhoef AF. The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine. Neth J Med. 2006;64:34–38. [PubMed] [Google Scholar]
  17. Wang XL, Adachi T, Sim AS, Wilcken DE. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18:1915–1921. doi: 10.1161/01.atv.18.12.1915. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of American Chemical Society

RESOURCES